AlloVir, Inc. - Common Stock (OQ:ALVR)

Mar 23, 2024 02:01 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines – ALVR
Pomerantz LLP announces that a class action lawsuit has been filed against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR). The class action, filed in the United States District Court for the District of Massachusetts, and docketed under...
Mar 19, 2024 04:10 pm ET
Shareholders of AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 19, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 19, 2024 10:30 am ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALVR
NEW YORK, NY / ACCESSWIRE / March 19, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 19, 2024 10:15 am ET
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allovir
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR) and reminds investors of the March 19, 2024 deadline to seek the role of lead...
Mar 19, 2024 07:15 am ET
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc.(ALVR) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / March 19, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 19, 2024 07:00 am ET
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 19, 2024 04:50 am ET
Shareholders of AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 19, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 19, 2024 04:30 am ET
Shareholders of AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 19, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 19, 2024 04:00 am ET
FINAL ALVR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AlloVir Inc. (“AlloVir” or “the Company”) (NASDAQ: ALVR) and certain of its...
Mar 18, 2024 12:45 pm ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 18, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 18, 2024 12:30 pm ET
ALLOVIR, INC. (NASDAQ: ALVR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against AlloVir, Inc.
Bernstein Liebhard LLP: Do you, or did you, own shares of AlloVir, Inc. (NASDAQ: ALVR)?Did you purchase your shares between March 22, 2022 and December 21, 2023, inclusive?Did you lose money in your investment in AlloVir, Inc.?Do you want to...
Mar 18, 2024 04:30 am ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVR
NEW YORK, NY / ACCESSWIRE / March 18, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 17, 2024 11:15 pm ET
Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / March 17, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 17, 2024 11:00 pm ET
FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 17, 2024 08:13 pm ET
Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR
NEW YORK, NY / ACCESSWIRE / March 17, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 17, 2024 08:00 pm ET
ALVR DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALVR
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, both dates inclusive (the “Class Period”), of the important March 19, 2024 lead plaintiff deadline.
Mar 17, 2024 01:07 pm ET
Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 17, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 17, 2024 07:07 am ET
Levi & Korsinsky Reminds AlloVir, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 17, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 16, 2024 10:00 pm ET
AlloVir, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 16, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 16, 2024 09:00 pm ET
ALLOVIR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against AlloVir, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR) in the United States District Court for...
Mar 15, 2024 07:00 pm ET
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of AlloVir, Inc.(ALVR) Shareholders
NEW YORK, NY / ACCESSWIRE / March 15, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 15, 2024 05:48 pm ET
ALVR DEADLINE ALERT: ROSEN, A LEADING AND RANKED FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important March 19 Deadline in Securities Class Action
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, both dates inclusive (the “Class Period”), of the important March 19, 2024 lead...
Mar 15, 2024 03:00 pm ET
Shareholders of AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 15, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 15, 2024 02:43 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines – ALVR
Pomerantz LLP announces that a class action lawsuit has been filed against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR). The class action, filed in the United States District Court for the District of Massachusetts, and docketed under...
Mar 15, 2024 07:00 am ET
4-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 15, 2024 04:30 am ET
Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 15, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 15, 2024 04:30 am ET
March 19, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - ALVR
NEW YORK, NY / ACCESSWIRE / March 15, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 14, 2024 11:55 am ET
Contact Levi & Korsinsky by March 19, 2024 Deadline to Join Class Action Against AlloVir, Inc. (ALVR)
NEW YORK, NY / ACCESSWIRE / March 14, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 14, 2024 11:30 am ET
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allovir
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR) and reminds investors of the March 19, 2024 deadline to seek the role of lead...
Mar 14, 2024 04:50 am ET
Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline 0 ALVR
NEW YORK, NY / ACCESSWIRE / March 14, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 14, 2024 04:40 am ET
Contact Levi & Korsinsky by March 19, 2024 Deadline to Join Class Action Against AlloVir, Inc.(ALVR)
NEW YORK, NY / ACCESSWIRE / March 14, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 14, 2024 01:00 am ET
March 19, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - ALVR
NEW YORK, NY / ACCESSWIRE / March 14, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 14, 2024 12:30 am ET
5-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 13, 2024 11:53 am ET
AlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights – ALVR
Levi & Korsinsky, LLP notifies investors in AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AlloVir investors who were adversely...
Mar 13, 2024 10:15 am ET
Shareholders that lost money on AlloVir, Inc. (ALVR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 13, 2024 08:20 am ET
AlloVir, Inc. Class Action: Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 13, 2024 05:30 am ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALVR
NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 13, 2024 05:30 am ET
Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALVR
NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 13, 2024 05:30 am ET
Shareholders that lost money on AlloVir, Inc. (ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR
NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 13, 2024 04:00 am ET
March 19, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALVR
NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 13, 2024 04:00 am ET
Shareholders of AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 13, 2024 03:00 am ET
6-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 12, 2024 03:15 pm ET
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc. (ALVR) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / March 12, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 12, 2024 12:59 pm ET
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit – ALVR
The Gross Law Firm issues the following notice to shareholders of AlloVir, Inc. Shareholders who purchased shares of ALVR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment...
Mar 12, 2024 07:15 am ET
AlloVir, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 12, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 12, 2024 07:00 am ET
7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ: ALVR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 12, 2024 04:50 am ET
Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 12, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 12, 2024 04:30 am ET
Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALVR
NEW YORK, NY / ACCESSWIRE / March 12, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 12, 2024 04:00 am ET
ALVR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AlloVir Inc. (“AlloVir” or “the Company”) (NASDAQ: ALVR) and certain of its...
Mar 11, 2024 03:00 pm ET
Levi & Korsinsky Reminds AlloVir, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 11, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 11, 2024 02:36 pm ET
ALVR DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action – ALVR
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, both dates inclusive (the “Class Period”), of the important March 19, 2024...
Mar 11, 2024 11:45 am ET
Levi & Korsinsky Reminds AlloVir, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 11, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 11, 2024 08:15 am ET
Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / March 11, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 11, 2024 08:00 am ET
ALLOVIR, INC. (NASDAQ: ALVR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against AlloVir, Inc.
Bernstein Liebhard LLP: Do you, or did you, own shares of AlloVir, Inc. (NASDAQ: ALVR)?Did you purchase your shares between March 22, 2022 and December 21, 2023, inclusive?Did you lose money in your investment in AlloVir, Inc.?Do you want to...
Mar 11, 2024 07:15 am ET
Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 11, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 11, 2024 07:00 am ET
MARCH 19 FINAL DEADLINE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 11, 2024 04:50 am ET
AlloVir, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 11, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 11, 2024 04:30 am ET
Contact Levi & Korsinsky by March 19, 2024 Deadline to Join Class Action Against AlloVir, Inc.(ALVR)
NEW YORK, NY / ACCESSWIRE / March 11, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 10, 2024 10:09 am ET
Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / March 10, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 10, 2024 09:13 am ET
Shareholders of AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 10, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 09, 2024 07:02 pm ET
Contact Levi & Korsinsky by March 19, 2024 Deadline to Join Class Action Against AlloVir, Inc.(ALVR)
NEW YORK, NY / ACCESSWIRE / March 9, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 09, 2024 08:00 am ET
INVESTOR DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 08, 2024 04:50 am ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 8, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 08, 2024 04:30 am ET
March 19, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALVR
NEW YORK, NY / ACCESSWIRE / March 8, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 08, 2024 04:00 am ET
ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / March 8, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 08, 2024 03:55 am ET
Shareholders of AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 8, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 08, 2024 03:30 am ET
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 07, 2024 11:00 am ET
Investors in AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 7, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 07, 2024 10:40 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines – ALVR
Pomerantz LLP announces that a class action lawsuit has been filed against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR). The class action, filed in the United States District Court for the District of Massachusetts, and docketed under...
Mar 07, 2024 10:00 am ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 7, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 07, 2024 09:45 am ET
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allovir
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR) and reminds investors of the March 19, 2024 deadline to seek the role of lead...
Mar 07, 2024 07:45 am ET
AlloVir, Inc. Class Action: Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 7, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 07, 2024 07:30 am ET
DEADLINE ALERT: Bernstein Liebhard LLP Reminds AlloVir, Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of AlloVir, Inc. (NASDAQ: ALVR)?Did you purchase your shares between March 22, 2022 and December 21, 2023, inclusive?Did you lose money in your investment in AlloVir, Inc.?Do you want to...
Mar 07, 2024 07:30 am ET
DEADLINE ALERT: Bernstein Liebhard LLP Reminds AlloVir, Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of AlloVir, Inc. (NASDAQ: ALVR)?Did you purchase your shares between March 22, 2022 and December 21, 2023, inclusive?Did you lose money in your investment in AlloVir, Inc.?Do you want to...
Mar 07, 2024 05:00 am ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVR
NEW YORK, NY / ACCESSWIRE / March 7, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 07, 2024 04:30 am ET
Contact Levi & Korsinsky by March 19, 2024 Deadline to Join Class Action Against AlloVir, Inc.(ALVR)
NEW YORK, NY / ACCESSWIRE / March 7, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 07, 2024 03:40 am ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 7, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 07, 2024 03:30 am ET
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 06, 2024 06:30 pm ET
Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 6, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 06, 2024 06:17 pm ET
ALVR INVESTORS: Lead Plaintiff Deadline is Approaching; Contact Robbins LLP for Information About Your Rights
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired AlloVir, Inc. (NASDAQ: ALVR) securities between March 11, 2022 and December 21, 2023. AlloVir, a...
Mar 06, 2024 06:15 pm ET
ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / March 6, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 06, 2024 06:00 pm ET
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action – ALVR
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, both dates inclusive (the “Class Period”), of the important March 19, 2024 lead...
Mar 06, 2024 01:15 pm ET
Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / March 6, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 06, 2024 01:00 pm ET
MARCH 19 DEADLINE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 06, 2024 05:00 am ET
AlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 6, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 06, 2024 04:35 am ET
ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / March 6, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 05, 2024 04:15 pm ET
ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / March 5, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 05, 2024 02:30 pm ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir Lawsuit - ALVR
NEW YORK, NY / ACCESSWIRE / March 5, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 05, 2024 02:15 pm ET
IMPORTANT MARCH DEADLINE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 05, 2024 11:42 am ET
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc. (ALVR) of a Class Action Lawsuit and an Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AlloVir investors who were adversely...
Mar 05, 2024 10:45 am ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 5, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 05, 2024 04:40 am ET
AlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 5, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 05, 2024 04:30 am ET
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of AlloVir, Inc.(ALVR) Shareholders
NEW YORK, NY / ACCESSWIRE / March 5, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 05, 2024 04:00 am ET
ALVR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AlloVir Inc. (“AlloVir” or “the Company”) (NASDAQ: ALVR) and certain of its...
Mar 04, 2024 09:30 pm ET
Lost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / March 4, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 04, 2024 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Dada, Cummins, Future FinTech, and AlloVir and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Dada Nexus Ltd. ADR (NASDAQ: DADA), Cummins Inc. (NYSE: CMI), Future FinTech...
Mar 04, 2024 06:00 pm ET
AlloVir, Inc. Class Action: Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 4, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 04, 2024 05:37 pm ET
AlloVir, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; March 19, 2024 deadline
The Portnoy Law Firm advises AlloVir, Inc. (“AlloVir or the “Company”) (NASDAQ: ALVR) investors that a lawsuit was filed on behalf of investors that purchased AlloVir securities between March 22, 2022 and December 21, 2023, inclusive (the “Class...
Mar 04, 2024 03:15 pm ET
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc. (ALVR) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / March 4, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 04, 2024 03:00 pm ET
IMPORTANT MARCH DEADLINE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Mar 04, 2024 11:45 am ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALVR
NEW YORK, NY / ACCESSWIRE / March 4, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 04, 2024 07:45 am ET
Investors who lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR
NEW YORK, NY / ACCESSWIRE / March 4, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 04, 2024 07:30 am ET
ALLOVIR, INC. (NASDAQ: ALVR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against AlloVir, Inc.
Bernstein Liebhard LLP: Do you, or did you, own shares of AlloVir, Inc. (NASDAQ: ALVR)?Did you purchase your shares between March 22, 2022 and December 21, 2023, inclusive?Did you lose money in your investment in AlloVir, Inc.?Do you want to...
Mar 04, 2024 04:40 am ET
AlloVir, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 4, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 04, 2024 04:40 am ET
Lost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / March 4, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 03, 2024 11:13 am ET
Levi & Korsinsky Reminds AlloVir, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / March 3, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 03, 2024 08:07 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / March 3, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 01, 2024 12:15 pm ET
AlloVir, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 1, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 01, 2024 09:45 am ET
AlloVir, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - ALVR
NEW YORK, NY / ACCESSWIRE / March 1, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 01, 2024 09:30 am ET
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allovir
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR) and reminds investors of the March 19, 2024 deadline to seek the role of lead...
Mar 01, 2024 04:40 am ET
Shareholders that lost money on AlloVir, Inc. (ALVR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / March 1, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Mar 01, 2024 04:30 am ET
AlloVir, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / March 1, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 29, 2024 09:30 pm ET
AlloVir, Inc. Class Action: Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 – ALVR
NEW YORK, NY / ACCESSWIRE / February 29, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 29, 2024 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Future FinTech, AlloVir, GrafTech, and Instacart and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Future FinTech Group Inc. (NASDAQ: FTFT), AlloVir, Inc. (NASDAQ: ALVR), GrafTech...
Feb 29, 2024 10:20 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / February 29, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 29, 2024 04:40 am ET
AlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / February 29, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 29, 2024 04:30 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / February 29, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 28, 2024 01:03 pm ET
Investors who lost money on AlloVir, Inc. (ALVR) should contact The Gross Law Firm about pending Class Action - ALVR
The Gross Law Firm issues the following notice to shareholders of AlloVir, Inc. Shareholders who purchased shares of ALVR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment...
Feb 28, 2024 11:00 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / February 28, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 28, 2024 10:32 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines – ALVR
Pomerantz LLP announces that a class action lawsuit has been filed against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR). The class action, filed in the United States District Court for the District of Massachusetts, and docketed under...
Feb 28, 2024 08:00 am ET
AlloVir, Inc. Class Action: Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / February 28, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 28, 2024 07:45 am ET
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of AlloVir, Inc.(ALVR) Shareholders
NEW YORK, NY / ACCESSWIRE / February 28, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 28, 2024 04:30 am ET
Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / February 28, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 28, 2024 04:30 am ET
Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR
NEW YORK, NY / ACCESSWIRE / February 28, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 28, 2024 01:20 am ET
March 19, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALVR
NEW YORK, NY / ACCESSWIRE / February 28, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 28, 2024 01:06 am ET
AlloVir, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; March 19, 2024 deadline
​The Portnoy Law Firm advises AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR) investors that a lawsuit was filed on behalf of investors that purchased AlloVir securities between March 22, 2022 and December 21, 2023, inclusive (the “Class...
Feb 27, 2024 02:00 pm ET
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc. (ALVR) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / February 27, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 27, 2024 04:45 am ET
Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR
NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR) of a class action securities lawsuit.
Feb 27, 2024 04:40 am ET
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of AlloVir, Inc.(ALVR) Shareholders
NEW YORK, NY / ACCESSWIRE / February 27, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 27, 2024 04:30 am ET
Contact Levi & Korsinsky by March 19, 2024 Deadline to Join Class Action Against AlloVir, Inc. (ALVR)
NEW YORK, NY / ACCESSWIRE / February 27, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 27, 2024 04:00 am ET
ALVR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AlloVir Inc. (“AlloVir” or “the Company”) (NASDAQ: ALVR) and certain of its...
Feb 26, 2024 05:30 pm ET
Shareholders of AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / February 26, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 26, 2024 04:00 pm ET
ALLOVIR, INC. (NASDAQ: ALVR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against AlloVir, Inc.
Bernstein Liebhard LLP: Do you, or did you, own shares of AlloVir, Inc. (NASDAQ: ALVR)?Did you purchase your shares between March 22, 2022 and December 21, 2023, inclusive?Did you lose money in your investment in AlloVir, Inc.?Do you want to...
Feb 26, 2024 12:27 pm ET
AlloVir, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – ALVR
Levi & Korsinsky, LLP notifies investors in AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AlloVir investors who were adversely...
Feb 26, 2024 11:45 am ET
Levi & Korsinsky Reminds AlloVir, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / February 26, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 26, 2024 04:50 am ET
Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / February 26, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 26, 2024 04:45 am ET
Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR
NEW YORK, NY / ACCESSWIRE / February 26, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 25, 2024 09:15 pm ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALVR
NEW YORK, NY / ACCESSWIRE / February 25, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 25, 2024 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Future FinTech, AlloVir, GrafTech, and Instacart and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Future FinTech Group Inc. (NASDAQ: FTFT), AlloVir, Inc. (NASDAQ: ALVR), GrafTech...
Feb 25, 2024 02:00 pm ET
Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR
NEW YORK, NY / ACCESSWIRE / February 25, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 25, 2024 07:13 am ET
Investors in AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / February 25, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 24, 2024 07:01 pm ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVR
NEW YORK, NY / ACCESSWIRE / February 24, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 23, 2024 06:00 pm ET
Kirby McInerney LLP Reminds Investors of Lead Plaintiff Deadline in AlloVir, Inc. (ALVR) Securities Class Action
The law firm of Kirby McInerney LLP reminds investors of the March 19, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those who acquired AlloVir, Inc. (“AlloVir” or the...
Feb 23, 2024 05:30 pm ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir Lawsuit - ALVR
NEW YORK, NY / ACCESSWIRE / February 23, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 23, 2024 05:21 pm ET
ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ALVR
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, both dates inclusive (the “Class Period”), of the important March 19, 2024...
Feb 23, 2024 11:00 am ET
AlloVir, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - ALVR
NEW YORK, NY / ACCESSWIRE / February 23, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 23, 2024 10:30 am ET
ALLOVIR SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss T
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR) and reminds investors of the March 19, 2024 deadline to seek the role of lead...
Feb 23, 2024 04:45 am ET
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc.(ALVR) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, Feb. 23, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR) of a class action securities lawsuit.
Feb 23, 2024 04:30 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / February 23, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 22, 2024 12:34 pm ET
Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 – ALVR
Levi & Korsinsky, LLP notifies investors in AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AlloVir investors who were adversely...
Feb 22, 2024 10:45 am ET
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of AlloVir, Inc.(ALVR) Shareholders
NEW YORK, NY / ACCESSWIRE / February 22, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 22, 2024 08:15 am ET
AlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / February 22, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 22, 2024 04:45 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law Firm
NEW YORK, Feb. 22, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of AlloVir, Inc..
Feb 22, 2024 04:30 am ET
AlloVir, Inc. Class Action: Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / February 22, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 22, 2024 04:30 am ET
Investors in AlloVir, Inc. Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / February 22, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 21, 2024 12:26 pm ET
Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action – Contact The Gross Law Firm to Learn More
The Gross Law Firm issues the following notice to shareholders of AlloVir, Inc.. Shareholders who purchased shares of ALVR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....
Feb 21, 2024 10:00 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / February 21, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 21, 2024 08:45 am ET
ALLOVIR SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Op
If you suffered losses exceeding $25,000 investing in AlloVir stock or options between March 22, 2022 and December 21, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/ALVR.
Feb 21, 2024 04:30 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / February 21, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 20, 2024 09:15 pm ET
Shareholders that lost money on AlloVir, Inc. (ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR
NEW YORK, NY / ACCESSWIRE / February 20, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 20, 2024 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Maison Solutions, Dada, Future FinTech, and AlloVir and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Maison Solutions Inc. (NASDAQ: MSS), Dada Nexus Ltd. ADR (NASDAQ: DADA), Future...
Feb 20, 2024 11:15 am ET
Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / February 20, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 20, 2024 10:51 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines – ALVR
Pomerantz LLP announces that a class action lawsuit has been filed against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR). The class action, filed in the United States District Court for the District of Massachusetts, and docketed under...
Feb 20, 2024 08:15 am ET
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of AlloVir, Inc. (ALVR) Shareholders
NEW YORK, NY / ACCESSWIRE / February 20, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 20, 2024 08:00 am ET
ALLOVIR, INC. (NASDAQ: ALVR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against AlloVir, Inc.
Bernstein Liebhard LLP: Do you, or did you, own shares of AlloVir, Inc. (NASDAQ: ALVR)?Did you purchase your shares between March 22, 2022 and December 21, 2023, inclusive?Did you lose money in your investment in AlloVir, Inc.?Do you want to...
Feb 20, 2024 04:45 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR) of a class action securities lawsuit.
Feb 20, 2024 04:30 am ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALVR
NEW YORK, NY / ACCESSWIRE / February 20, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 20, 2024 04:30 am ET
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc.(ALVR) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / February 20, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 20, 2024 04:00 am ET
ALVR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AlloVir Inc. (“AlloVir” or “the Company”) (NASDAQ: ALVR) and certain of its...
Feb 19, 2024 04:30 am ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / February 19, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 19, 2024 04:30 am ET
Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / February 19, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 18, 2024 07:13 am ET
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc.(ALVR) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / February 18, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 17, 2024 07:01 pm ET
Lost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / February 17, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 17, 2024 05:33 pm ET
ROSEN, A TOP RANKED LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALVR
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, both dates inclusive (the “Class Period”), of the important March 19, 2024 lead...
Feb 16, 2024 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Maison Solutions, Dada, Future FinTech, and AlloVir and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Maison Solutions Inc. (NASDAQ: MSS), Dada Nexus Ltd. ADR (NASDAQ: DADA), Future...
Feb 16, 2024 01:15 pm ET
AlloVir, Inc. Class Action: Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / February 16, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 16, 2024 12:30 pm ET
Levi & Korsinsky Reminds AlloVir, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / February 16, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 16, 2024 11:45 am ET
ALLOVIR SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Op
If you suffered losses exceeding $25,000 investing in AlloVir stock or options between March 22, 2022 and December 21, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/ALVR.
Feb 16, 2024 04:30 am ET
ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / February 16, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 16, 2024 04:30 am ET
Levi & Korsinsky Reminds AlloVir, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, NY / ACCESSWIRE / February 16, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 16, 2024 04:00 am ET
Levi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR
NEW YORK, Feb. 16, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR) of a class action securities lawsuit.
Feb 15, 2024 01:45 pm ET
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir Lawsuit - ALVR
NEW YORK, NY / ACCESSWIRE / February 15, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 15, 2024 12:20 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVR
NEW YORK, Feb. 15, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR). The class action, filed in the United States District Court for the District of Massachusetts, and docketed under 24-cv-10152, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired AlloVir securities between March 22, 2022 and December 21, 2023, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the
Feb 15, 2024 09:30 am ET
Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR
NEW YORK, NY / ACCESSWIRE / February 15, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 15, 2024 09:15 am ET
ALLOVIR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Direc
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR) and reminds investors of the March 19, 2024 deadline to seek the role of lead...
Feb 15, 2024 08:15 am ET
AlloVir, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / February 15, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 15, 2024 04:30 am ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / February 15, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 15, 2024 04:30 am ET
Levi & Korsinsky Notifies Shareholders of AlloVir, Inc. (ALVR) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / February 15, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 14, 2024 01:00 pm ET
Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join – Contact Levi & Korsinsky
Levi & Korsinsky, LLP notifies investors in AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AlloVir investors who were adversely...
Feb 14, 2024 04:30 am ET
AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR
NEW YORK, NY / ACCESSWIRE / February 14, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 13, 2024 11:00 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / February 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 13, 2024 08:15 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / February 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 13, 2024 08:00 am ET
ALLOVIR, INC. (NASDAQ: ALVR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against AlloVir, Inc.
Bernstein Liebhard LLP: Do you, or did you, own shares of AlloVir, Inc. (NASDAQ: ALVR)?Did you purchase your shares between March 22, 2022 and December 21, 2023, inclusive?Did you lose money in your investment in AlloVir, Inc.?Do you want to...
Feb 13, 2024 07:15 am ET
Investors Who Lost Money on AlloVir, Inc.(ALVR) Should Contact Levi & Korsinsky About Pending Class Action - ALVR
NEW YORK, NY / ACCESSWIRE / February 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 13, 2024 07:00 am ET
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / February 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AlloVir, Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Feb 13, 2024 04:45 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, Feb. 13, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR) of a class action securities lawsuit.
Feb 13, 2024 04:20 am ET
Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / February 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Feb 13, 2024 04:20 am ET
Investors who lost money on AlloVir, Inc. (ALVR) should contact Levi & Korsinsky about pending Class Action - ALVR
NEW YORK, NY / ACCESSWIRE / February 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.